HIGHLIGHTS
- who: Claire L. Storey from the patients presenting with stage III NSCLC in The Netherlandss University have published the article: Practical implications to contemplate when considering radical therapy for stage III non-small-cell lung cancer, in the Journal: (JOURNAL)
- what: Stage III NSCLC is a heterogeneous disease with both tumour extent and patient fitness being important factors in advising the optimum treatment.
SUMMARY
Published 29 assess a patient for treatment, (b) deliver chemotherapy concurrently, (c) deliver radiotherapy in the concurrent setting and_(d) provide supportive care for patients receiving CRT . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.